Molecular alterations monitoring in myelodysplastic patients receiving an allogeneic hematopoietic stem cell transplantation after a reduced-intensity conditioning regimen

被引：0
|
作者：
Robin, Marie [1 ]
Nibourel, Olivier [2 ]
Tournaire, Martin [3 ]
Michonneau, David [1 ]
Preudhomme, Claude [2 ]
Verbanck, Marie [3 ]
Xhaard, Alienor [1 ]
Ades, Lionel [4 ]
de Fontbrune, Flore Sicre [1 ]
Sebert, Marie [4 ]
Fenaux, Pierre [4 ]
Socie, Gerard [1 ]
de Latour, Regis Peffault [1 ]
Curis, Emmanuel [3 ,5 ]
机构：
[1] Univ Paris Cite, Hop St Louis, Hematol Greffe, Paris, France
[2] Univ Lille, CHU Lille, CANTHER Canc Heterogene Plast & Resistance Therapi, CNRS,Inserm,UMR9020,U1277, F-59000 Lille, France
[3] Univ Paris Cite, Fac Pharm Paris, UR 7537, BioSTM, 4 Ave Observ, F-75014 Paris, France
[4] Univ Paris, Hop St Louis, Hematol, Paris, France
[5] Hop Lariboisiere, AP HP, Lab Hematol, 2 Rue Ambroise Pare, F-75010 Paris, France
来源：
BONE MARROW TRANSPLANTATION | 2024年 / 59卷 / 09期
关键词：
DONOR AVAILABILITY; RESIDUAL DISEASE; LEUKEMIA;
D O I：
10.1038/s41409-024-02314-2
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1309 / 1312
页数：4
相关论文
共 50 条
  • [21] Association between conditioning intensity and height growth after allogeneic hematopoietic stem cell transplantation in children
    Uemura, Suguru
    Hasegawa, Daiichiro
    Kishimoto, Kenji
    Fujikawa, Tomoko
    Nakamura, Sayaka
    Kozaki, Aiko
    Saito, Atsuro
    Ishida, Toshiaki
    Mori, Takeshi
    Ozaki, Kayo
    Kosaka, Yoshiyuki
    CANCER MEDICINE, 2023, 12 (16): : 17018 - 17027
  • [22] Modified Busulfan and Cyclophosphamide Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Patients With Hematologic Malignancies
    Zhao, X. F.
    Mao, X. F.
    Wan, D. M.
    Liu, W.
    TRANSPLANTATION PROCEEDINGS, 2014, 46 (05) : 1531 - 1535
  • [23] Cord blood transplantation with a reduced-intensity conditioning regimen for patients with relapsed aggressive multiple myeloma after cytoreduction with bortezomib
    Kasahara, Ikumi
    Nishio, Mitsufumi
    Yamamoto, Satoshi
    Endo, Tomoyuki
    Fujimoto, Katsuya
    Yamaguchi, Keisuke
    Takeda, Yukari
    Goto, Hideki
    Sato, Norihiro
    Koike, Takao
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 90 (03) : 413 - 415
  • [24] Long-term outcomes of fludarabine, melphalan and antithymocyte globulin as reduced-intensity conditioning regimen for allogeneic hematopoietic stem cell transplantation in children with primary immunodeficiency disorders: a prospective single center study
    Hamidieh, A. A.
    Behfar, M.
    Pourpak, Z.
    Faghihi-Kashani, S.
    Fazlollahi, M. R.
    Hosseini, A. S.
    Movahedi, M.
    Mozafari, M.
    Moin, M.
    Ghavamzadeh, A.
    BONE MARROW TRANSPLANTATION, 2016, 51 (02) : 219 - 226
  • [25] Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome
    Alessandrino, Emilio Paolo
    Della Porta, Matteo G.
    Malcovati, Luca
    Jackson, Christopher H.
    Pascutto, Cristiana
    Bacigalupo, Andrea
    van Lint, Maria Teresa
    Falda, Michele
    Bernardi, Massimo
    Onida, Francesco
    Guidi, Stefano
    Iori, Anna Paola
    Cerretti, Raffaella
    Marenco, Paola
    Pioltelli, Pietro
    Angelucci, Emanuele
    Oneto, Rosi
    Ripamonti, Francesco
    Rambaldi, Alessandro
    Bosi, Alberto
    Cazzola, Mario
    Levis, A.
    Rambaldi, A.
    Bandini, G.
    Casini, M.
    Rossi, G.
    Angelucci, E.
    Baronciani, D.
    La Nasa, G.
    Milone, G.
    Mordini, N.
    Guidi, S.
    Bosi, A.
    Bacigalupo, A.
    Van Lint, M. T.
    Corradini, P.
    Milani, R.
    Morra, E.
    Marenco, P.
    Deliliers, G. Lambertenghi
    Onida, F.
    Ciceri, F.
    Bernardi, M.
    Castagna, L.
    Narni, F.
    Pioltelli, P.
    Selleri, Carmine
    Scime, R.
    Iannitto, E.
    Musso, M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (07) : 581 - 588
  • [26] Lenalidomide plus donor-lymphocytes infusion after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with high-risk multiple myeloma
    El-Cheikh, Jean
    Crocchiolo, Roberto
    Furst, Sabine
    Ladaique, Patrick
    Castagna, Luca
    Faucher, Catherine
    Granata, Angela
    Oudin, Claire
    Lemarie, Claude
    Calmels, Boris
    Stoppa, Anne-Marie
    De Colella, Jean-Marc Schiano
    Duran, Segolene
    Chabannon, Christian
    Blaise, Didier
    EXPERIMENTAL HEMATOLOGY, 2012, 40 (07) : 521 - 527
  • [27] Health-Related Quality of Life in Patients Undergoing Allogeneic Stem Cell Transplantation After Reduced Intensity Conditioning Versus Myeloablative Conditioning
    Andersson, Inger
    Ahlberg, Karin
    Stockelberg, Dick
    Brune, Mats
    Persson, Lars-Olof
    CANCER NURSING, 2009, 32 (04) : 325 - 334
  • [28] Second allogeneic hematopoietic stem cell transplantation in patients with acute leukemia relapsed after allogeneic hematopoietic stem cell transplantation
    Choi, Yunsuk
    Choi, Eun-Ji
    Lee, Jung-Hee
    Lee, Kyoo-Hyung
    Jo, Jae-Cheol
    Park, Han-Seung
    Lee, Yoo Jin
    Seol, Miee
    Lee, Young-Shin
    Kang, Young-Ah
    Jeon, Mijin
    Lee, Je-Hwan
    CLINICAL TRANSPLANTATION, 2021, 35 (03)
  • [29] Cost-Effectiveness of Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Older Patients With High-Risk Myelodysplastic Syndrome: Analysis of BMT CTN 1102
    Saber, Wael
    Bansal, Aasthaa
    Li, Lily
    Scott, Bart L.
    Sangaralingham, Lindsey R.
    Thao, Viengneesee
    Roth, Joshua A.
    Wright, Winona
    Steuten, Lotte M. G.
    Pidala, Joseph A.
    Mishra, Asmita
    Maziarz, Richard T.
    Westervelt, Peter
    McGuirk, Joseph P.
    Cutler, Corey
    Nakamura, Ryotaro
    Ramsey, Scott D.
    JCO ONCOLOGY PRACTICE, 2024, 20 (04) : 572 - 580
  • [30] Total costs and clinical outcome of hematopoietic stem cell transplantation in adults with leukemia: comparison between reduced-intensity and myeloablative conditioning
    Suh, Koung Jin
    Kim, Inho
    Lim, Jin
    Ha, Hyerim
    Park, Seongyeol
    Koh, Youngil
    Yoon, Sung-Soo
    Park, Seonyang
    CLINICAL TRANSPLANTATION, 2015, 29 (02) : 124 - 133
12345